High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus A Perniok, F Wedekind, M Herrmann, C Specker, M Schneider Lupus 7 (2), 113-118, 1998 | 283 | 1998 |
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID) HP Tony, G Burmester, H Schulze-Koops, M Grunke, J Henes, I Kötter, ... Arthritis research & therapy 13, 1-14, 2011 | 244 | 2011 |
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 211 | 2021 |
Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study L Cavagna, L Nuno, CA Scire, M Govoni, FJL Longo, F Franceschini, ... Medicine 94 (32), e1144, 2015 | 181 | 2015 |
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 167 | 2019 |
Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging B Ostendorf, A Scherer, C Specker, U Mödder, M Schneider Arthritis & Rheumatism 48 (1), 157-165, 2003 | 157 | 2003 |
Glucocorticoid receptors in rheumatoid arthritis R Schlaghecke, E Kornely, JÜR Wollenhaupt, C Specker Arthritis & Rheumatism: Official Journal of the American College of …, 1992 | 139 | 1992 |
Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity N Nirmala, A Brachat, E Feist, N Blank, C Specker, M Witt, J Zernicke, ... Pediatric Rheumatology 13, 1-6, 2015 | 131 | 2015 |
Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome R Fischer-Betz, C Specker Best practice & research Clinical rheumatology 31 (3), 397-414, 2017 | 126 | 2017 |
Self-assessments of patients via Tablet PC in routine patient care: comparison with standardised paper questionnaires JG Richter, A Becker, T Koch, M Nixdorf, R Willers, R Monser, B Schacher, ... Annals of the rheumatic diseases 67 (12), 1739-1741, 2008 | 123 | 2008 |
S2e-Leitlinie Therapie der rheumatoiden Arthritis mit krankheitsmodifizierenden Medikamenten C Fiehn, J Holle, C Iking-Konert, J Leipe, C Weseloh, M Frerix, R Alten, ... Springer Medizin, 2018 | 118 | 2018 |
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases R Hasseli, U Mueller-Ladner, BF Hoyer, A Krause, HM Lorenz, A Pfeil, ... RMD open 7 (1), e001464, 2021 | 116 | 2021 |
Interdisziplinäre leitlinie management der frühen rheumatoiden arthritis M Schneider, M Lelgemann, HH Abholz, M Blumenroth, C Flügge, ... Springer, 2011 | 107 | 2011 |
Current state of evidence on ‘off-label’therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland … M Aringer, H Burkhardt, GR Burmester, R Fischer-Betz, M Fleck, ... Lupus 21 (4), 386-401, 2012 | 103 | 2012 |
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised … GR Burmester, F Buttgereit, C Bernasconi, JM Álvaro-Gracia, N Castro, ... The Lancet 396 (10246), 267-276, 2020 | 101 | 2020 |
The German national registry of primary immunodeficiencies (2012–2017) SM El-Helou, AK Biegner, S Bode, SR Ehl, M Heeg, ME Maccari, ... Frontiers in immunology 10, 1272, 2019 | 97 | 2019 |
Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine R Fischer-Betz, C Specker, R Brinks, M Aringer, M Schneider Rheumatology 52 (6), 1070-1076, 2013 | 97 | 2013 |
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE)–results from a nationwide cohort in Germany (GRAID) M Witt, M Grunke, F Proft, M Baeuerle, M Aringer, G Burmester, G Chehab, ... Lupus 22 (11), 1142-1149, 2013 | 95 | 2013 |
Acquired factor VIII inhibitors in nonhemophilic patients D Söhngen, C Specker, D Bach, BME Kuntz, M Burk, C Aul, G Kobbe, ... Annals of hematology 74, 89-93, 1997 | 94 | 1997 |
Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra). R Fischer-Betz, C Specker, M Schneider Clinical and experimental rheumatology 29 (6), 1021-1023, 2011 | 86 | 2011 |